premium The Indonesian Stock Exchange has decided to revoke the temporary suspension of trading shares of PT MNC Studio International Tbk (MSIN) on Monday (12/7).
premium The rupiah exchange rate has the potential to experience pressure against the US dollar on Monday (12/7), triggered by market concerns about the increase in new global COVID-19 cases due to the delta variant.
premium The positive sentiment of global and regional markets became the driving force for strengthening the Jakarta Composite Index (JCI) at the opening of trading Monday (12/7) by 20.21 points.
premium PT Aneka Tambang Tbk (ANTM), until July 2021, spent Rp25.86 billion for exploration costs. Its exploration activities focused on gold, nickel, and bauxite commodities.
premium PT Garuda Indonesia (Persero) Tbk states that it fully respects the ongoing legal process.
premium PT MNC Investama Tbk (BHIT) has set the price for implementing the limited public offering VIII in 2021 with the Pre-emptive Rights at Rp173 per share.
The Jakarta Composite Index at the beginning of the week (12/7) has the opportunity to experience a correction by moving to the support and resistance levels of 5,913-6,123
premium PT Kalbe Farma Tbk (KLBF) has received approval from the Food and Drug Supervisory Agency BPOM to conduct a Phase 2b/3 clinical trial for the COVID-19 GX-19N vaccine in Indonesia.
premium PT Kalbe Farma Tbk (KLBF) has received approval from the Food and Drug Supervisory Agency BPOM to conduct a Phase 2b/3 clinical trial for the COVID-19 GX-19N vaccine in Indonesia.
premium PT Adhi Karya (Persero) Tbk announced that the construction of the Jabodebek LRT infrastructure phase I until July 2, 2021, has reached 85.75%.
premium PT Adhi Karya (ADH)I realized the acquisition of a new contract of Rp6.7 trillion in the first half of the year.
premium PT Bio Farma (Persero) stated that individual mutual assistance vaccines are not for booster injections.